Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma.
Carlo MI, Molina AM, Lakhman Y, Patil S, Woo K, DeLuca J, Lee CH, Hsieh JJ, Feldman DR, Motzer RJ, Voss MH. Carlo MI, et al. Among authors: molina am. Oncologist. 2016 Jul;21(7):787-8. doi: 10.1634/theoncologist.2016-0145. Epub 2016 Jun 10. Oncologist. 2016. PMID: 27286790 Free PMC article. Clinical Trial.
Targeting renal cell carcinoma.
Motzer RJ, Molina AM. Motzer RJ, et al. Among authors: molina am. J Clin Oncol. 2009 Jul 10;27(20):3274-6. doi: 10.1200/JCO.2009.21.8461. Epub 2009 May 18. J Clin Oncol. 2009. PMID: 19451422 No abstract available.
mTOR inhibitors in advanced renal cell carcinoma.
Voss MH, Molina AM, Motzer RJ. Voss MH, et al. Among authors: molina am. Hematol Oncol Clin North Am. 2011 Aug;25(4):835-52. doi: 10.1016/j.hoc.2011.04.008. Hematol Oncol Clin North Am. 2011. PMID: 21763970 Free PMC article. Review.
115 results